Session » Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

Date: Tuesday, November 12, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2263

A Qualitative Study Evaluating Near-Patient Tools Including a Mobile Application for Earlier RA Referral; Potential to Reduce Chronic Disease Burden

9:00AM-11:00AM: Abstract Number: 2255

Adherence to Subcutaneous Anti-tnf Therapies in Chronic Inflammatory Rheumatism and Therapeutic Education

9:00AM-11:00AM: Abstract Number: 2258

Causes of Influenza Vaccine Hesitancy in Rheumatoid Arthritis and Adults with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2253

Comparing Patient and Provider Perspectives on Long Term Biologic Use and Tapering in Stable, Well-Controlled Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2250

Contribution of Personality Traits, Psychological Factors and Health Related Quality of Life on Medication Adherence in Patients with RA

9:00AM-11:00AM: Abstract Number: 2242

Evaluating Important Change in Cutaneous Disease Activity as an Efficacy Measure for Clinical Trials in Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2262

Evaluation of Illness Perception in Systemic Sclerosis Patients with Pulmonary Involvement

9:00AM-11:00AM: Abstract Number: 2249

Evaluation of Rheumatoid Arthritis Patients’ Preferences Using Discrete Choice Experiment

9:00AM-11:00AM: Abstract Number: 2237

Gathering Patients’ and Physicians’ Perceptions to Improve Outcomes in Systemic Autoimmune Myopathies

9:00AM-11:00AM: Abstract Number: 2243

Knowledge, Needs and Expectations Among Systemic Lupus Erythematosus: Preliminary Results from the INTEGRATE Pilot Project

9:00AM-11:00AM: Abstract Number: 2248

Legal Matters: Attitudes Regarding Marijuana for Medical Use Among Patients with Rheumatic and Musculoskeletal Disease

9:00AM-11:00AM: Abstract Number: 2240

Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2241

Parent Perspectives on Addressing Emotional Health for Youth with Juvenile Myositis: A Qualitative Focus Group Study

9:00AM-11:00AM: Abstract Number: 2257

Patient and Clinical Characteristics Associated with Increased Willingness to Adopt RA Treatment After an Educational Intervention: An Analysis of the Confident Treatment Decisions for Living with Rheumatoid Arthritis (CONTROL-RA) Trial

9:00AM-11:00AM: Abstract Number: 2256

Patient Beliefs and Perceptions of Methotrexate for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2247

Patient Factors Associated with Willingness to Change Rheumatoid Arthritis Medications

9:00AM-11:00AM: Abstract Number: 2260

Patients’ Journeys Through Giant Cell Arteritis: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 2259

Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group

9:00AM-11:00AM: Abstract Number: 2245

Polymyositis (PM) and Dermatomyositis (DM) Symptom Flares and Associated Impact from the Patient Perspective

9:00AM-11:00AM: Abstract Number: 2261

Post Traumatic Stress Disorder in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2264

Prescribing Exercise: Facilitators and Barriers to the Successful Implementation of Physical Activity Guidelines in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 2239

Reproductive Health Awareness and Needs: Assessment of Parents, Female Adolescents, and Young Adults with Pediatric Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2238

Role of Clinical Impact, Disease-specific Knowledge and Beliefs About Medication on Therapeutic Adherence in Rheumatoid Arthritis: An Integrative Structural Equation Modeling Approach

9:00AM-11:00AM: Abstract Number: 2236

Strength Training for People with Rheumatoid Arthritis: Barriers, Facilitators, and Tailoring Considerations

9:00AM-11:00AM: Abstract Number: 2246

Symptoms and Impacts in Psoriatic Arthritis: Findings from Qualitative Patient Interviews

9:00AM-11:00AM: Abstract Number: 2252

The #Worldlupusday 2019 Across Twitter: An Explorative Analysis of Spreading Concepts and Sentiment Perceptions on Social Media

9:00AM-11:00AM: Abstract Number: 2265

The Effects of Message Framing on Patients’ Perceptions and Willingness to Switch to a Biosimilar

9:00AM-11:00AM: Abstract Number: 2254

The Urge for Mobile Apps in Rheumatology – a German Patient Perspective

9:00AM-11:00AM: Abstract Number: 2251

Understanding Vulnerabilities in Diagnosis and Care of Childhood and Adult-Onset Lupus: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 2244

What Are the Prescribing Trends and Satisfaction Levels with Analgesics for Osteoarthritis as Reported by US Rheumatogists, Orthopaedic Surgeons, and Primary Care Physicians?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].